Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: J Am Acad Dermatol. 2020 Feb 25;83(5):1450–1452. doi: 10.1016/j.jaad.2020.02.053

Table 1.

Demographics and prevalence of moderate-to-severe acne in transgender adultsa

All TMb TFc P
Characteristics, N (%) 696 (100) 346 (49.7) 350 (50.3)
Age at time of survey (years) <0.001
 18–29 217 (31.2) 148 (42.8) 69 (19.7)
 30–39 156 (22.4) 104 (30.1) 52 (14.9)
 40–54 168 (24.1) 69 (19.9) 99 (28.3)
 ≥55 155 (22.3) 25 (7.2) 130 (37.1)
Race/ethnicity 0.66
 Non-Hispanic White 392 (56.3) 191 (55.2) 201 (57.4)
 Non-Hispanic Black 20 (2.9) 13 (3.8) 7 (2.0)
 Non-Hispanic Asian/Pacific Islander 48 (6.9) 25 (7.2) 23 (6.6)
 Hispanic 133 (19.1) 68 (19.7) 65 (18.6)
 Other / Declined 103 (14.8) 49 (14.2) 54 (15.4)
History of gender-affirming treatmentsd <0.001
 None 28 (4.0) 11 (3.2) 17 (4.9)
 Hormone therapy only 234 (33.6) 76 (22.0) 158 (45.1)
 Chest surgery without genital surgery 171 (24.6) 142 (41.0) 29 (8.3)
 Genital surgery with or without chest surgery 233 (33.5) 103 (19.8) 130 (37.2)
 Missing information 30 (4.3) 14 (4.1) 16 (4.6)
Moderate-to-severe acne diagnosis by a physiciane <0.001
 No 449 (64.5) 208 (60.1) 241 (68.9)
 Yes - currently 50 (7.2) 47 (13.6) 3 (0.9)
 Yes - in the past 95 (13.7) 50 (14.5) 45 (12.9)
 Missing information 102 (14.7) 41 (11.9) 61 (17.4)
Ever diagnosis of moderate or severe acne (current or past) 145 (20.8) 97 (28.0) 48 (13.7) <0.001
Moderate or severe acne linked to hormone therapy <0.001
 No 76 (53.9) 33 (34.4) 43 (95.6)
 Yes 65 (46.1) 63 (65.6) 2 (4.4)
Any visit to a dermatologist 347 (49.9) 154 (44.5) 193 (55.1) <0.001

TM, transmasculine; TF, transfeminine

a

Numbers may not add up to the total number of participants because, unless otherwise specified, we excluded categories with missing data totaling less than 5%.

b

Transmasculine refers to transgender persons with current gender identity that differs from female natal sex

c

Transfeminine refers to transgender persons with current gender identity that differs from male natal sex

d

Chest surgery referred to any history of mastectomy or breast augmentation, while genital surgery referred to any history of hysterectomy, orchiectomy, vaginectomy, and/or vaginoplasty. The majority (98.3%) of respondents with a history of chest surgery and/or genital surgery has received hormone therapy.

e

We combined the missing category with no prior history of moderate-to-severe acne to produce conservative estimates of current moderate-to-severe acne prevalence. Acne prevalence may be underestimated in transfeminine persons given higher levels of missing acne data.